A new meta-analysis of randomized controlled trials of inhibitors of the renin–angiotensin system highlights the clinical benefits of these agents and underscores their potential in the ...

Effect of inhibitors of the renin–angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366 , 2026–2033 (2005). Article CAS Google ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

Because of the pivotal role of angiotensin II in the different steps of the cardiovascular continuum, more complete inhibition of the RAS to reduce the overall cardiovascular risk of an individual ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...

was looking at gene expression data from the lung fluid of COVID-19 patients on his computer screen when he spotted something striking—the expression of genes for key enzymes in the renin-angiotensin ...

The class of drugs, known as renin–angiotensin system (RAS) inhibitors, block the effects of the renin enzyme, relaxing blood vessels and allowing blood to flow more easily. They are widely used ...

The focus for Hallberg and his colleagues was primarily to better understand a hormonal system in the body called the renin-angiotensin system (RAS). It regulates blood pressure and fluid balance ...